Product Image

Contributor Information

  • Name Julin Wong ; David Lane
  • Institute A*STAR Accelerate Technologies Pte Ltd

Tool Details

  • Tool name: Anti-c-Met [13]
  • Clone: 13
  • Tool type: Antibodies
  • Tool sub-type: Primary antibody
  • Class: Monoclonal
  • Conjugate: Unconjugated
  • Reactivity: Human
  • Host: Mouse
  • Application: FACS ; IF ; IP ; WB
  • Description: c-Met is a tyrosine receptor kinase which is activated by its ligand, the hepatocyte growth factor. Activation of c-Met leads to a wide spectrum of biological activities such as motility, angiogenesis, morphogenesis, cell survival and cell regeneration. c-Met is abnormally activated in many tumour types. Aberrant c-Met activation was found to induce tumour development, tumour cell migration and invasion, and the worst and final step in cancer progression, metastasis.
  • Immunogen: Bacterially expressed human c-Met alpha chain
  • Isotype: IgG1 kappa
  • Research area: Cancer; Cell signaling and signal transduction; Genetics
  • Myeloma used: Sp2/0-Ag14

  • For Research Use Only

Target Details

  • Target: c-Met, cMet
  • Target background: c-Met is a tyrosine receptor kinase which is activated by its ligand, the hepatocyte growth factor. Activation of c-Met leads to a wide spectrum of biological activities such as motility, angiogenesis, morphogenesis, cell survival and cell regeneration. c-Met is abnormally activated in many tumour types. Aberrant c-Met activation was found to induce tumour development, tumour cell migration and invasion, and the worst and final step in cancer progression, metastasis.

Application Details

  • Application: FACS ; IF ; IP ; WB

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15°C to -25°C
  • Shipping conditions: Shipping at 4°C

Documentation

References

  •   Wong et al. 2013. Oncotarget. 4(7):1019-36. PMID: 23859937.
  •   Anti-c-Met antibodies recognising a temperature sensitive epitope, inhibit cell growth.